Смирнова Дарья Александровна, к.м.н.

Руководитель Института психического здоровья, Университет “Реавиз”, г.Санкт-Петербург, Россия

В коротком сообщении будет представлена информация об уникальном стиле наставничества безвременно ушедшего в 2022 году профессора Петра Викторовича Морозова и его важной роли в формировании стратегии академического развития поколений специалистов, начинающих профессиональную деятельность и успешно реализующих карьеру в учреждениях системы психиатрического здравоохранения в России.

Диалог добра через поколения:

• Добрые слова многого не стоят. И все же они многого добились. (Блез Паскаль)
• Доброта — это то, что может услышать глухой и увидеть слепой. (Марк Твен)
• Делайте свое добро там, где вы есть; эти маленькие кусочки добра, собранные вместе, переполняют мир. (Десмонд Туту)
• Доброта — это золотая цепь, скрепляющая общество. (Иоганн Вольфганг фон Гёте)
• Что важнее – быть добрым или умным? Ответ каждого мне всегда интересен. (Петр Викторович Морозов)
• Доброта важнее мудрости, и признание этого – начало мудрости. (Теодор Исаак Рубин)

Juan Evangelista Tercero Gaitán Buitrago, Dr., Quindío, Columbia

Psychiatrist Addiction specialist Fellow in Dementia and Cognitive decline
Specialist in Cognitive Behavioral therapy Member of the International scientific commitee – Argentinian society of Personality disorders and psychopaties.
Member of the International Foundation for the development of neuroscience
Chair of the scientific commitee – Global Psychiatric Association
Member of the section on psychoneuroendocrinology – World Psychiatric Association
Member of the section on evidence based psychiatry – World Psychiatric Association
CEO Grupo T.E.C.

The treatment of the patient suffering from dementia has been a complex clinical challenge, this presentation focuses on the topic of supplementing current interdisciplinary approaches with the addition of musical stimulation. This approach aims to facilitate the daily interaction of the patient and its caretakers, presenting it as a neurobiological, social and occupational intervention, by facilitating the activation of the default mode network, the social engagement of the patient and the promotion of physical wellbeing. The author gives an overview of the the different strategies of musical therapy, ranging from individual, group and familiar modes of treatment. Also presented is a successful case where music therapy helped an otherwise difficult dementia patient with severe behavioral disturbance.

Prof. Petr Morozov, MD, PhD, DMedSc (Psychiatry), Russia

Department of Psychiatry, Faculty of Advanced Medical Studies, Russian
National Medical Research University n.a. Pirogov, Moscow, Russia
Russian Society of Psychiatrists Vice-President
World Psychiatric Association General Secretary

This lecture discovers unique historical, clinical and prognostic issues of the Kandinsky-Clerambault syndrome. Though the syndrome, its symptomatology and relation to schizophrenia are well known, many professionals are not familiar with its eponymic term. Clinical representations of the syndrome and its biological correlates are discussed through the prism of impressive historical retrospective.

Prof. Xenia Gonda, MA (Psychology), PhD (Psychiatry), PharmD, Budapest, Hungary

Department of Psychiatry and Psychotherapy, Semmelweis University New Antidepressant Target Group & MTA-SE Neurochemistry and Neuropsychopharmacology Research group, Semmelweis University and Hungarian Academy of Sciences Laboratory of Suicide Prevention and Research, National Institute for Psychiatry and Addictology

Suicide has a huge impact not only on the lives of patients and their families but also mental healthcare, public health and the society in general. In spite of these, we face several unmet needs in understanding, prevention and management of suicide. Our current methods of screening and predicting are highly unspecific and have a low predictive value, thus novel approaches to the etiology of suicide are needed to develop reliable biomarkers. An increased inflammatory state is present in suicidal patients with elevated levels of proinflammatory cytokines and a typical inflammatory signature profile. Based on understanding these processes we have the hope of repurposing currently used antiinflammatory molecules and developing novel ones which specifically target neuroinflammatory components of suicide.